[{"data":1,"prerenderedAt":254},["ShallowReactive",2],{"options:asyncdata:$edqCtX92v0:/blogs/the-nci-k-frequently-asked-questions:0":3},{"blogPost":4,"otherBlogs":77},{"id":5,"date":6,"date_gmt":6,"guid":7,"modified":6,"modified_gmt":6,"slug":9,"status":10,"type":11,"link":12,"title":13,"content":15,"excerpt":18,"author":20,"featured_media":21,"comment_status":22,"ping_status":22,"sticky":17,"template":19,"format":23,"meta":24,"categories":26,"tags":27,"class_list":28,"featured_media_src_url":35,"_links":36},701,"2026-08-14T13:52:50",{"rendered":8},"https://wp.ncikenya.go.ke/?p=701","the-nci-k-frequently-asked-questions","publish","post","https://wp.ncikenya.go.ke/2026/08/14/the-nci-k-frequently-asked-questions/",{"rendered":14},"THE NCI-K FREQUENTLY ASKED QUESTIONS",{"rendered":16,"protected":17},"\n\u003Cdiv data-wp-interactive=\"core/file\" class=\"wp-block-file\">\u003Cobject data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/08/FREQUENTLY-ASKED-QUESTIONS.pdf\" type=\"application/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of FREQUENTLY ASKED QUESTIONS.\">\u003C/object>\u003Ca id=\"wp-block-file--media-f588684c-c8b2-4c62-b33a-0be4d748438d\" href=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/08/FREQUENTLY-ASKED-QUESTIONS.pdf\">FREQUENTLY ASKED QUESTIONS\u003C/a>\u003Ca href=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/08/FREQUENTLY-ASKED-QUESTIONS.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-f588684c-c8b2-4c62-b33a-0be4d748438d\">Download\u003C/a>\u003C/div>\n",false,{"rendered":19,"protected":17},"",1,0,"open","standard",{"pagelayer_contact_templates":25,"_pagelayer_content":19,"footnotes":19},[],[20],[],[29,11,30,31,32,33,34],"post-701","type-post","status-publish","format-standard","hentry","category-uncategorized",null,{"self":37,"collection":43,"about":46,"author":49,"replies":53,"version-history":56,"predecessor-version":59,"wp:attachment":63,"wp:term":66,"curies":73},[38],{"href":39,"targetHints":40},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/701",{"allow":41},[42],"GET",[44],{"href":45},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts",[47],{"href":48},"https://wp.ncikenya.go.ke/wp-json/wp/v2/types/post",[50],{"embeddable":51,"href":52},true,"https://wp.ncikenya.go.ke/wp-json/wp/v2/users/1",[54],{"embeddable":51,"href":55},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=701",[57],{"count":20,"href":58},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/701/revisions",[60],{"id":61,"href":62},703,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/701/revisions/703",[64],{"href":65},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=701",[67,70],{"taxonomy":68,"embeddable":51,"href":69},"category","https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=701",{"taxonomy":71,"embeddable":51,"href":72},"post_tag","https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=701",[74],{"name":75,"href":76,"templated":51},"wp","https://api.w.org/{rel}",[78,135,197],{"id":79,"date":80,"date_gmt":80,"guid":81,"modified":80,"modified_gmt":80,"slug":83,"status":10,"type":11,"link":84,"title":85,"content":87,"excerpt":89,"author":20,"featured_media":91,"comment_status":22,"ping_status":22,"sticky":17,"template":19,"format":23,"meta":92,"categories":94,"tags":95,"class_list":96,"featured_media_src_url":99,"_links":100},683,"2026-06-19T10:09:43",{"rendered":82},"https://wp.ncikenya.go.ke/?p=683","nci-kenya-supports-historic-launch-of-kilifi-countys-first-cancer-centre","https://wp.ncikenya.go.ke/2026/06/19/nci-kenya-supports-historic-launch-of-kilifi-countys-first-cancer-centre/",{"rendered":86},"NCI-Kenya Supports Historic Launch of Kilifi County’s First Cancer Centre.",{"rendered":88,"protected":17},"\n\u003Cp class=\"wp-block-paragraph\">The National Cancer Institute of Kenya (NCI-K) joined Kilifi County, development partners, and stakeholders in celebrating a major milestone in Kenya’s cancer control efforts with the official commissioning of the first-ever Cancer Centre at Kilifi County Referral Hospital.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The landmark event, hosted by H.E. Governor Gideon Maitha Mung’aro, was attended by H.E. Arnaud Suquet, Ambassador of France to Kenya, Mr. Amin Mawji, OBE, Diplomatic Representative of the Aga Khan Development Network in Kenya, representatives from the Ministry of Health, county leadership, development partners, and other key stakeholders committed to strengthening cancer care services in Kenya.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The establishment of the Cancer Centre marks a significant step towards improving access to quality cancer care for residents of Kilifi County and the wider Coastal region. For many years, patients seeking oncology services have been forced to travel long distances to access specialized treatment, often resulting in financial hardship, delayed care, and poor treatment outcomes. The introduction of chemotherapy services at the facility will bring life-saving treatment closer to patients and improve timely access to cancer care.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">NCI-Kenya played a critical role in supporting the realization of this milestone as part of its mandate to coordinate and promote cancer prevention, early detection, treatment, palliative care, research, and partnerships across the country. Through close collaboration with the Ministry of Health, Kilifi County Government, the National Cancer Control Programme, development partners, and healthcare institutions, NCI-K continues to support efforts aimed at decentralizing cancer services and strengthening cancer care infrastructure at the county level.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The launch of the centre aligns with Kenya’s broader objective of expanding access to comprehensive cancer care and reducing disparities in service delivery. It also reflects the growing impact of strategic partnerships in advancing the national cancer control agenda.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Looking ahead, Kilifi County has outlined plans to further strengthen the facility by establishing comprehensive oncology services, including radiotherapy through the acquisition of a Linear Accelerator (LINAC) and enhanced breast cancer screening through investment in digital mammography technology. These developments will contribute significantly to improving cancer outcomes through timely diagnosis and treatment.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Speaking during the event, leaders acknowledged the importance of collaboration in making the project a reality. NCI-Kenya was recognized as one of the key partners whose technical support, coordination, and commitment contributed to the successful establishment of the Cancer Centre. The commissioning of the Kilifi County Cancer Centre marks a significant milestone in Kenya’s journey towards equitable cancer care. The facility brings hope to patients and families by expanding access to quality cancer services closer to home and reducing the burden of travelling long distances for treatment. NCI-Kenya remains committed to working with national and county governments, healthcare providers, and development partners to strengthen cancer prevention, early detection, treatment, and care services across the country.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003C/p>\n",{"rendered":90,"protected":17},"\u003Cp>The National Cancer Institute of Kenya (NCI-K) joined Kilifi County, development partners, and stakeholders in celebrating a major milestone in Kenya’s cancer control efforts with the official commissioning of the first-ever Cancer Centre at Kilifi County Referral Hospital. The landmark event, hosted by H.E. Governor Gideon Maitha Mung’aro, was attended by H.E. Arnaud Suquet, Ambassador […]\u003C/p>\n",684,{"pagelayer_contact_templates":93,"_pagelayer_content":19,"footnotes":19},[],[20],[],[97,11,30,31,32,98,33,34],"post-683","has-post-thumbnail","https://wp.ncikenya.go.ke/wp-content/uploads/2026/06/WhatsApp-Image-2026-06-18-at-11.54.40-PMG.jpeg",{"self":101,"collection":106,"about":108,"author":110,"replies":112,"version-history":115,"predecessor-version":118,"wp:featuredmedia":122,"wp:attachment":125,"wp:term":128,"curies":133},[102],{"href":103,"targetHints":104},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/683",{"allow":105},[42],[107],{"href":45},[109],{"href":48},[111],{"embeddable":51,"href":52},[113],{"embeddable":51,"href":114},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=683",[116],{"count":20,"href":117},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/683/revisions",[119],{"id":120,"href":121},685,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/683/revisions/685",[123],{"embeddable":51,"href":124},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media/684",[126],{"href":127},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=683",[129,131],{"taxonomy":68,"embeddable":51,"href":130},"https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=683",{"taxonomy":71,"embeddable":51,"href":132},"https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=683",[134],{"name":75,"href":76,"templated":51},{"id":136,"date":137,"date_gmt":137,"guid":138,"modified":140,"modified_gmt":140,"slug":141,"status":10,"type":11,"link":142,"title":143,"content":145,"excerpt":147,"author":20,"featured_media":149,"comment_status":22,"ping_status":22,"sticky":17,"template":19,"format":23,"meta":150,"categories":152,"tags":155,"class_list":156,"featured_media_src_url":160,"_links":161},707,"2026-09-03T04:12:11",{"rendered":139},"https://wp.ncikenya.go.ke/?p=707","2026-09-03T06:18:42","university-of-manchester-team-visits-nci-k-to-explore-opportunities-for-cancer-research-and-capacity-building-collaboration","https://wp.ncikenya.go.ke/2026/09/03/university-of-manchester-team-visits-nci-k-to-explore-opportunities-for-cancer-research-and-capacity-building-collaboration/",{"rendered":144},"University of Manchester Team Visits NCI-K to Explore Opportunities for Cancer Research, Training and Capacity-Building Collaboration",{"rendered":146,"protected":17},"\n\u003Cp class=\"wp-block-paragraph\">The National Cancer Institute-Kenya (NCI-K) hosted a delegation from the University of Manchester and its cancer research and clinical partners for an engagement focused on strengthening collaboration in cancer research, screening, diagnostics, training, mentorship and capacity building.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The visiting team was received by the \u003Cstrong>NCI-K Chief Executive Officer\u003C/strong>, Dr. Elias Melly, who highlighted the Institute’s mandate and its ongoing efforts to strengthen cancer control through research, evidence generation, innovation and strategic partnerships.\u003C/p>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large is-resized\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"759\" src=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/DSC_5159-1024x759.jpg\" alt=\"\" class=\"wp-image-712\" style=\"aspect-ratio:1.349195973329847;width:563px;height:auto\" srcset=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/DSC_5159-1024x759.jpg 1024w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/DSC_5159-300x222.jpg 300w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/DSC_5159-767x568.jpg 767w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/DSC_5159-1536x1138.jpg 1536w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/DSC_5159-2048x1517.jpg 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" />\u003C/figure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cem>\u003Cstrong>From left,\u003C/strong> \u003Cstrong>Professor Sacha Howell – Division of Cancer Sciences; Professor Robert Bristow\u003C/strong> – \u003Cstrong>Director, Manchester Cancer Research Centre; Dr. Elias Melly, CEO, NCI-k\u003C/strong> and \u003Cstrong>Rachel Chown\u003C/strong> — \u003Cstrong>Associate Director, Integrated Research and Education Strategy, The Christie NHS Foundation Trust.\u003C/strong>\u003C/em>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">During the visit, the delegation was briefed on the \u003Cstrong>National Cancer Registry\u003C/strong>, including cancer data collection, analysis and reporting in Kenya. The team also received a presentation on the \u003Cstrong>NCI-K Cancer Data Dashboard\u003C/strong>, showcasing the latest available \u003Cstrong>2024 cancer data\u003C/strong> and its role in informing cancer planning, policy, research and service delivery.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The delegation was further taken through \u003Cstrong>research projects supported by NCI-K through its Seed Grant Programme\u003C/strong>, highlighting the Institute’s commitment to promoting locally relevant research and building Kenya’s cancer research capacity.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Exploring Areas of Strategic Collaboration\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Discussions focused on areas where the complementary strengths of NCI-K and the Manchester cancer research ecosystem could support advances across the cancer care and research continuum.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">A key area was \u003Cstrong>breast cancer screening and imaging\u003C/strong>, including strengthening national mammography services, improving screening uptake in rural and urban settings, and exploring the application of \u003Cstrong>artificial intelligence and machine learning in mammographic image interpretation and cancer detection\u003C/strong>.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The teams also explored opportunities for collaboration in \u003Cstrong>lung cancer screening\u003C/strong>, with a focus on generating evidence to inform appropriate screening approaches and strengthening early detection.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Other areas identified included \u003Cstrong>histopathology and diagnostic capacity\u003C/strong>, particularly through assessing skills gaps and developing targeted approaches to strengthen specialist expertise, laboratory capacity and cancer diagnostics.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Strengthening Training, Fellowships and Mentorship\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The engagement also explored opportunities for \u003Cstrong>fellowships, mentorship and structured training programmes\u003C/strong> for Kenyan researchers and healthcare professionals. Discussions included the development of \u003Cstrong>online learning modules, short-term training programmes and other flexible professional development opportunities\u003C/strong>.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">These areas align with Manchester’s established strength in cancer education, clinical research and workforce development. The Manchester Cancer Research Centre brings together \u003Cstrong>The University of Manchester, The Christie NHS Foundation Trust and Cancer Research UK\u003C/strong>, creating an integrated environment in which basic science, translational research and clinical practice are closely connected. The Centre’s research strategy spans multiple cancer types and links basic, translational and clinical research through a wider network of externally funded institutes, centres and research programmes.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Genomics, AI and Precision Cancer Research\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The discussions further identified opportunities for joint research in \u003Cstrong>genomics, artificial intelligence and machine learning\u003C/strong>, including the use of advanced technologies to improve cancer diagnosis, understand disease biology and support data-driven cancer research.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Manchester has significant expertise in \u003Cstrong>cancer genomics and data science\u003C/strong>, with ongoing international research programmes examining the genetic basis of cancer and opportunities to improve early detection and treatment. Importantly, Manchester already has an active research collaboration in \u003Cstrong>Kenya on oesophageal cancer\u003C/strong>, led by Professor Rob Bristow in partnership with Kenyan researchers, focusing on early detection and the genetic changes associated with oesophageal squamous cell cancer.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The teams also discussed opportunities to explore the application of \u003Cstrong>AI in research methodologies\u003C/strong>, including innovative approaches to study design and participant randomisation.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The engagement highlighted the potential for NCI-K and Manchester to build on complementary strengths: \u003Cstrong>NCI-K’s national cancer data, research mandate and understanding of Kenya’s cancer landscape\u003C/strong>, alongside Manchester’s expertise in \u003Cstrong>cancer genomics, precision oncology, imaging, artificial intelligence, clinical research, translational science, education and multidisciplinary cancer care\u003C/strong>.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The Manchester Cancer Research Centre is a world-leading comprehensive cancer research partnership, bringing together scientists, clinicians and research institutions to accelerate the translation of discoveries into improved cancer prevention, diagnosis and treatment. Its strong international outlook and existing collaborations in Kenya provide a valuable foundation for expanding research and capacity-building partnerships.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">NCI-K and the University of Manchester will continue discussions to translate the areas identified into practical programmes that can contribute to \u003Cstrong>strengthening cancer research, innovation, early detection, diagnostics, workforce development and cancer control in Kenya\u003C/strong>.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>University of Manchester Delegation\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The delegation included:\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Rachel Chown\u003C/strong> — \u003Cstrong>Associate Director, Integrated Research and Education Strategy, The Christie NHS Foundation Trust.\u003C/strong> Rachel previously served at the Manchester Cancer Research Centre, where she led training and education and supported international links, academic collaborations, and research-related education programmes.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Professor Robert Bristow\u003C/strong> — \u003Cstrong>Director, Manchester Cancer Research Centre (MCRC); Director, Cancer Research UK Manchester Centre; University Professor of Cancer Studies, University of Manchester; and Senior Group Leader in Translational Oncogenomics at the Cancer Research UK Manchester Institute.\u003C/strong> Professor Bristow’s research includes cancer genomics, tumour biology, DNA damage and repair, and treatment response.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Professor Sacha Howell\u003C/strong> is a professor in the Division of Cancer Sciences at the University of Manchester and a leading breast cancer clinician-researcher. His research focuses on breast cancer treatment and prevention, breast cancer risk prediction, imaging and mammographic density, with links to research in artificial intelligence and mammographic imaging.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003C/p>\n",{"rendered":148,"protected":17},"\u003Cp>The National Cancer Institute-Kenya (NCI-K) hosted a delegation from the University of Manchester and its cancer research and clinical partners for an engagement focused on strengthening collaboration in cancer research, screening, diagnostics, training, mentorship and capacity building. The visiting team was received by the NCI-K Chief Executive Officer, Dr. Elias Melly, who highlighted the Institute’s […]\u003C/p>\n",708,{"pagelayer_contact_templates":151,"_pagelayer_content":19,"footnotes":19},[],[153,154],4,43,[],[157,11,30,31,32,98,33,158,159],"post-707","category-news-updates","category-partnerships","https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/DSC_5237-1024x683.jpg",{"self":162,"collection":167,"about":169,"author":171,"replies":173,"version-history":176,"predecessor-version":180,"wp:featuredmedia":184,"wp:attachment":187,"wp:term":190,"curies":195},[163],{"href":164,"targetHints":165},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/707",{"allow":166},[42],[168],{"href":45},[170],{"href":48},[172],{"embeddable":51,"href":52},[174],{"embeddable":51,"href":175},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=707",[177],{"count":178,"href":179},7,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/707/revisions",[181],{"id":182,"href":183},720,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/707/revisions/720",[185],{"embeddable":51,"href":186},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media/708",[188],{"href":189},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=707",[191,193],{"taxonomy":68,"embeddable":51,"href":192},"https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=707",{"taxonomy":71,"embeddable":51,"href":194},"https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=707",[196],{"name":75,"href":76,"templated":51},{"id":198,"date":199,"date_gmt":199,"guid":200,"modified":202,"modified_gmt":202,"slug":203,"status":10,"type":11,"link":204,"title":205,"content":207,"excerpt":209,"author":20,"featured_media":211,"comment_status":22,"ping_status":22,"sticky":17,"template":19,"format":23,"meta":212,"categories":214,"tags":215,"class_list":216,"featured_media_src_url":218,"_links":219},721,"2026-09-25T17:34:12",{"rendered":201},"https://wp.ncikenya.go.ke/?p=721","2026-09-27T07:03:42","kenyas-efforts-to-advance-cancer-prevention-screening-early-detection-and-access-to-care","https://wp.ncikenya.go.ke/2026/09/25/kenyas-efforts-to-advance-cancer-prevention-screening-early-detection-and-access-to-care/",{"rendered":206},"Kenya’s Efforts to Advance Cancer Prevention, Screening, Early Detection and Access to Care.",{"rendered":208,"protected":17},"\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>25\u003Csup>th\u003C/sup> September, 2026 – Hong Kong, China\u003C/strong> — Presenting at the World Cancer Congress 2026, Emily Barsito, the Head of Strategic Planning, Resource Mobilization and Partnerships Directorate at NCI-Kenya, presented Kenya’s progress and experience in strengthening cancer prevention, screening, early detection and access to quality cancer care.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The presentation, \u003Cstrong>“Kenya’s Efforts on Cancer Prevention, Screening, Early Detection and Access to Care,”\u003C/strong> highlighted the country’s efforts to build a coordinated and equitable national cancer-control system, while drawing lessons that may be relevant to other low- and middle-income countries.\u003C/p>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"1024\" src=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/734522-768x1024-1.jpg\" alt=\"\" class=\"wp-image-730\" srcset=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/734522-768x1024-1.jpg 768w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/734522-225x300.jpg 225w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/734522.jpg 960w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" />\u003C/figure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cem>Emily Barsito Presenting on Kenya’s  Efforts on Cancer Prevention, Screening, Early Detection and Access to Care\u003C/em>.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Strengthening Cancer Prevention through Governance and Policy\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya’s response to the growing cancer burden is anchored in the \u003Cstrong>Cancer Prevention and Control Act, 2012\u003C/strong>, which established the National Cancer Institute of Kenya (NCI-K) to spearhead and coordinate cancer prevention and control nationally.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Through NCI-K and a multisectoral approach, Kenya continues to strengthen leadership and coordination in cancer prevention and control, public information, education and awareness, and implementation of the National Cancer Control Strategy.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Investing in Cancer Prevention\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Prevention remains a key pillar of Kenya’s cancer-control efforts.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Public information, education and awareness initiatives are being used to increase knowledge about cancer risk factors, prevention and the importance of screening, while creating demand for early detection services.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya has also strengthened tobacco control as an important public-health intervention, including restrictions on smoking in public spaces to reduce population exposure to tobacco smoke.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>HPV Vaccination and Cervical Cancer Prevention\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya continues to advance efforts towards the elimination of cervical cancer through HPV vaccination.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">More than \u003Cstrong>four million girls aged 9–14 years\u003C/strong> have been vaccinated through school-based programmes and integration of HPV vaccination into primary healthcare.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">This investment in prevention is critical to reducing the future burden of cervical cancer and protecting generations of Kenyan women.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Bringing Screening Closer to Communities\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya has integrated cancer screening with \u003Cstrong>primary healthcare (PHC)\u003C/strong> to improve access to preventive and early-detection services.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The country has also embraced innovative and culturally appropriate approaches to screening and awareness, including reaching underserved and hard-to-reach populations.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Integrating cancer prevention and screening into primary healthcare provides an opportunity to bring services closer to communities and strengthen early detection across the country.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Strengthening Early Detection and Diagnosis\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Early diagnosis remains essential to improving cancer outcomes.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya has invested in advanced oncology and diagnostic technologies, including \u003Cstrong>CT, MRI and PET-CT\u003C/strong>, to strengthen diagnosis, staging and treatment planning.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">These investments support the country’s ambition to shift cancer diagnosis from predominantly \u003Cstrong>Stage III and IV disease towards Stage I and II\u003C/strong>, when treatment can be more effective and outcomes improved.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Decentralising Cancer Care\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Access to quality cancer care is being strengthened through the decentralisation of oncology services and the establishment of \u003Cstrong>regional cancer centres\u003C/strong> capable of providing comprehensive cancer treatment.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">This approach is helping reduce geographical disparities and bringing specialised cancer services closer to patients and their families.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Sustainable health financing is equally important. Kenya’s \u003Cstrong>Universal Health Coverage (UHC)\u003C/strong> agenda and the \u003Cstrong>Social Health Insurance Fund (SHIF)\u003C/strong> oncology package are intended to reduce the financial burden associated with cancer treatment and protect families from catastrophic health expenditure.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Using Cancer Data to Guide Action\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Reliable data is fundamental to effective cancer prevention and control.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya’s \u003Cstrong>National Cancer Registry\u003C/strong> provides critical information to support evidence-based policy, planning, resource allocation, research and evaluation of cancer-control interventions.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Without reliable data, countries risk making decisions without a clear understanding of where the burden lies, who is affected and where resources are most needed.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Lessons for other Low- and Middle-Income Countries\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya’s experience offers several lessons that may be relevant to other countries facing similar challenges:\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>1. Good governance is essential.\u003C/strong>\u003Cbr>Strong leadership, coordination and accountability provide the backbone for resilient cancer-control systems.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>2. Prevention is the best investment.\u003C/strong>\u003Cbr>Countries should prioritise preventing cancers wherever effective prevention interventions are available.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>3. Decentralise cancer care.\u003C/strong>\u003Cbr>Bringing services closer to communities can reduce geographical and socioeconomic inequalities in access to care.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>4. Integrate cancer services with primary healthcare.\u003C/strong>\u003Cbr>Integration provides a practical pathway for expanding prevention, awareness and screening services.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>5. Invest in sustainable health financing.\u003C/strong>\u003Cbr>Cancer care should be accessible to those who need it, not only to those who can afford it.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>6. Build reliable cancer information systems.\u003C/strong>\u003Cbr>Cancer data is the lifeblood of effective planning, resource allocation and programme evaluation. Without it, decision-making remains largely blind.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>7. Leverage innovation to advance equity.\u003C/strong>\u003Cbr>Technology and innovation should be deliberately deployed to expand access, improve quality and address the needs of underserved populations.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>A shared commitment to cancer control\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya’s experience demonstrates that progress in cancer control requires more than investment in treatment alone. It requires \u003Cstrong>strong governance, prevention, early detection, accessible screening, reliable data, sustainable financing, innovation and equitable access to care\u003C/strong>.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">As countries work towards reducing the growing global cancer burden, sharing experiences and learning from one another can help accelerate progress—particularly in low- and middle-income settings.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Kenya remains committed to strengthening its cancer-control systems and advancing equitable access to prevention, early detection and quality cancer care for all.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>#NCIK #HealthGovernance #CancerPreventionAndControlAct #PublicHealthPolicy #CancerControl #CancerPrevention #CancerScreening #EarlyDetection #UniversalHealthCoverage\u003C/strong>\u003C/p>\n",{"rendered":210,"protected":17},"\u003Cp>25th September, 2026 – Hong Kong, China — Presenting at the World Cancer Congress 2026, Emily Barsito, the Head of Strategic Planning, Resource Mobilization and Partnerships Directorate at NCI-Kenya, presented Kenya’s progress and experience in strengthening cancer prevention, screening, early detection and access to quality cancer care. The presentation, “Kenya’s Efforts on Cancer Prevention, Screening, […]\u003C/p>\n",734,{"pagelayer_contact_templates":213,"_pagelayer_content":19,"footnotes":19},[],[153],[],[217,11,30,31,32,98,33,158],"post-721","https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/734523-768x1024.jpg",{"self":220,"collection":225,"about":227,"author":229,"replies":231,"version-history":234,"predecessor-version":237,"wp:featuredmedia":241,"wp:attachment":244,"wp:term":247,"curies":252},[221],{"href":222,"targetHints":223},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/721",{"allow":224},[42],[226],{"href":45},[228],{"href":48},[230],{"embeddable":51,"href":52},[232],{"embeddable":51,"href":233},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=721",[235],{"count":153,"href":236},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/721/revisions",[238],{"id":239,"href":240},735,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/721/revisions/735",[242],{"embeddable":51,"href":243},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media/734",[245],{"href":246},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=721",[248,250],{"taxonomy":68,"embeddable":51,"href":249},"https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=721",{"taxonomy":71,"embeddable":51,"href":251},"https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=721",[253],{"name":75,"href":76,"templated":51},1792071275795]